Speaker Details

Vidya Uprety

Vidya Uprety

Medicines Development for Global Health

BIOGRAPHY

Vidya Uprety is the Principal Clinical Project Manager at Medicines Development for Global Health (MDGH). MDGH headquartered in Melbourne, Australia, is a Not-for-Profit Pharmaceutical Company developing medicines to ease the burden of neglected diseases. With over 18 years of clinical research experience Vidya holds a Bachelor of Science and a Postgraduate Diploma in Clinical Research and Data Management. Vidya has extensive expertise in clinical trial management, GCP compliance, and regulatory oversight. Vidya recently led the successful completion of a Phase II clinical trial evaluating a novel treatment for scabies titled: A Phase 2, Placebo-controlled, Double-blind, Randomized, Dose Ranging, Efficacy and Safety Study of Orally Administered Moxidectin in Adults With Scabies. Vidya will present the study results for the first time at a scientific meeting, highlighting the efficacy and safety findings. The study results are publicly available on ClinicalTrials.gov.

SESSIONS

F001 Future of Dermatology: Dermatology Beyond 2040
Jul 16, 2026 1:00 PM - 4:45 PM Mercury Ballroom

DISCLOSURES

No financial relationships exist with ineligible companies.